Who owns Ovid Therapeutics?
- Ticker: OVID
- CUSIP Number: 690469101
Tip: Access positions for across all investors
Analyze quarterly positions in Ovid Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ovid Therapeutics stock
Who bought or sold Ovid Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Takeda Pharmaceutical | 7.5M | $9.8M | 0% | Sep 2025 |
|
| Vanguard Group | 2.8M | $3.7M | 7% | Sep 2025 |
|
| Affinity Asset Advisors | 2.7M | $3.4M | 297% | Sep 2025 |
|
| Acadian Asset Management | 2.3M | $3.0M | 8% | Sep 2025 |
|
| Renaissance Technologies | 2.0M | $2.6M | -4% | Sep 2025 |
|
| Sio Capital Management | 1.4M | $1.9M | -36% | Sep 2025 |
|
| Driehaus Capital Management | 1.4M | $1.8M | 0% | Sep 2025 |
|
| Adage Capital Partners GP | 1.4M | $1.8M | 17% | Sep 2025 |
|
| Kennedy Capital Management | 1.1M | $1.4M | -26% | Sep 2025 |
|
| Ikarian Capital | 1.1M | $1.4M | 100% | Sep 2025 |
|
| Millennium Management | 986k | $1.3M | -6% | Sep 2025 |
|
| Assenagon Asset Management | 925k | $1.2M | 112% | Sep 2025 |
|
| Schonfeld Strategic Advisors | 883k | $1.1M | 100% | Sep 2025 |
|
| Marshall Wace | 784k | $1.0M | 376% | Sep 2025 |
|
| Wells Fargo & Company | 731k | $950k | -4% | Sep 2025 |
|
| Geode Capital Management | 648k | $843k | 1% | Sep 2025 |
|
| Susquehanna International | 647k | $841k | 181% | Sep 2025 |
|
| Balyasny Asset Management | 625k | $813k | 100% | Sep 2025 |
|
| BlackRock | 611k | $795k | -55% | Sep 2025 |
|
| Walleye Trading Advisors | 597k | $776k | 100% | Sep 2025 |
|
| Citadel Advisors | 546k | $710k | 3402% | Sep 2025 |
|
| Boothbay Fund Management | 487k | $633k | 100% | Sep 2025 |
|
| Simplex Trading | 388k | $503k | 100% | Sep 2025 |
|
| Two Sigma Investments | 341k | $444k | 100% | Sep 2025 |
|
| GSA Capital Partners | 266k | $346k | -64% | Sep 2025 |
|
| Jane Street | 238k | $310k | 67% | Sep 2025 |
|
| UBS Group | 238k | $309k | 998% | Sep 2025 |
|
| State Street Corporation | 227k | $295k | 0% | Sep 2025 |
|
| Parkman Healthcare Partners | 203k | $264k | 100% | Sep 2025 |
|
| Group One Trading | 188k | $245k | 100% | Sep 2025 |
|
| Diadema Partners | 188k | $244k | 100% | Sep 2025 |
|
| XTX Topco | 183k | $238k | 134% | Sep 2025 |
|
| Velan Capital Investment Management | 160k | $208k | 0% | Sep 2025 |
|
| Two Sigma Advisers | 152k | $197k | 100% | Sep 2025 |
|
| Northern Trust | 152k | $197k | 53% | Sep 2025 |
|
| Squarepoint Ops | 115k | $149k | -48% | Sep 2025 |
|
| Bridgeway Capital Management | 95k | $124k | 0% | Sep 2025 |
|
| Empowered Funds | 91k | $119k | 0% | Sep 2025 |
|
| Cubist Systematic Strategies | 87k | $113k | 2137% | Sep 2025 |
|
| Bank of New York Mellon | 58k | $75k | 0% | Sep 2025 |
|
| Integrated Wealth Concepts | 53k | $69k | 100% | Sep 2025 |
|
| FMR | 47k | $61k | 0% | Sep 2025 |
|
| Abel Hall | 32k | $42k | 0% | Sep 2025 |
|
| Goldman Sachs Group | 29k | $37k | -73% | Sep 2025 |
|
| Apollon Wealth Management | 28k | $36k | 100% | Sep 2025 |
|
| First Manhattan | 26k | $34k | 0% | Sep 2025 |
|
| Private Advisor | 26k | $33k | 100% | Sep 2025 |
|
| Qube Research & Technologies | 25k | $33k | -65% | Sep 2025 |
|
| William Blair $ Company | 25k | $33k | 14% | Sep 2025 |
|
| Point72 Asia | 19k | $25k | -50% | Sep 2025 |
|
| TLS Advisors | 19k | $26k | -97% | Sep 2025 |
|
| Cetera Investment Advisers | 17k | $22k | 100% | Sep 2025 |
|
| H D Vest Advisory Services | 17k | $5.6k | 100% | Jun 2025 |
|
| Quadcap Wealth Management | 15k | $20k | 100% | Sep 2025 |
|
| ADAR1 Capital Management | 13k | $17k | -89% | Sep 2025 |
|
| LPL Financial | 12k | $16k | 100% | Sep 2025 |
|
| Two Sigma Securities | 12k | $15k | 100% | Sep 2025 |
|
| Allspring Global Investments Holdings | 11k | $15k | -71% | Sep 2025 |
|
| Aaron Wealth Advisors | 11k | $15k | -71% | Sep 2025 |
|
| Morgan Stanley | 11k | $3.5k | 100% | Jun 2025 |
|
| Sovereign Financial Group | 10k | $13k | 100% | Sep 2025 |
|
| Royal Bank of Canada | 4.6k | $5.5k | -32% | Sep 2025 |
|
| Jpmorgan Chase & Co | 2.9k | $3.8k | -100% | Sep 2025 |
|
| NISA Investment Advisors | 2.4k | $3.1k | 0% | Sep 2025 |
|
| Tower Research Capital | 2.3k | $3.0k | -95% | Sep 2025 |
|
| Union Bankshares | 2.3k | $3.0k | 0% | Sep 2025 |
|
| North Star Investment Management | 1.0k | $1.4k | 100% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 962.00 | $1.3k | 11% | Sep 2025 |
|
| Pnc Financial Services | 903.00 | $1.2k | 0% | Sep 2025 |
|
| SBI Securities | 425.00 | $553.010000 | -52% | Sep 2025 |
|
| Advisory Services Network | 219.00 | $285.006600 | 100% | Sep 2025 |
|
| Point72 | 197.00 | $256.001500 | -85% | Sep 2025 |
|
| SRS Capital Advisors | 140.00 | $182.000000 | 100% | Sep 2025 |
|
| Barclays | 71.00 | $92.001800 | 0% | Sep 2025 |
|
| TD Waterhouse Canada | 30.00 | $41.001000 | 0% | Sep 2025 |
|
| CWM | 23.00 | $0 | -98% | Sep 2025 |
|
| Sound Income Strategies | 6.00 | $10.000200 | 0% | Sep 2025 |
|
| Advisor Group Holdings | 5.00 | $6.000000 | 0% | Sep 2025 |
|
Who sold out of Ovid Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| BVF | Jun 2025 | 3.9M | $1.3M |
| Madison Avenue Partners | Jun 2025 | 1.3M | $433k |
| Rosalind Advisors | Jun 2025 | 500k | $165k |
| Rubric Capital Management | Jun 2025 | 479k | $158k |
| Y-Intercept | Jun 2025 | 160k | $53k |
| Hrt Financial | Jun 2025 | 123k | $40k |
| Hsbc Holdings | Jun 2025 | 19k | $6.0k |
| Newman Dignan & Sheerar | Jun 2025 | 17k | $5.5k |
| AQR Capital Management | Jun 2025 | 16k | $5.2k |
| PFG Investments | Jun 2025 | 14k | $4.6k |
| Jump Financial | Jun 2025 | 14k | $4.5k |
| Cibc World Markets | Mar 2025 | 13k | $4.1k |
| Virtu Financial | Jun 2025 | 13k | $4.0k |
| EverSource Wealth Advisors | Jun 2025 | 24.00 | $7.999200 |
| True Wealth Design | Jun 2025 | 8.00 | $3.000000 |